Dienone compounds: targets and pharmacological responses

M Bazzaro, S Linder - Journal of medicinal chemistry, 2020 - ACS Publications
The biological responses to dienone compounds with a 1, 5-diaryl-3-oxo-1, 4-pentadienyl
pharmacophore have been studied extensively. Despite their expected general thiol …

Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties

RK Anchoori, M Tan, SH Tseng, S Peng, RS Soong… - PLoS …, 2020 - journals.plos.org
We sought to design ubiquitin-proteasome system inhibitors active against solid cancers by
targeting ubiquitin receptor RPN13 within the proteasome's 19S regulatory particle. The …

Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors

RK Anchoori, L George, SH Tseng, B Lam… - Plos one, 2021 - journals.plos.org
Bortezomib and the other licensed 20S proteasome inhibitors show robust activity against
liquid tumors like multiple myeloma, but have disappointed against solid tumors including …

Evaluation of anti-inflammatory diphenyldihaloketone EF24 in transient ischemic stroke model

A Mdzinarishvili, H Houson, A Hedrick, V Awasthi - Brain Injury, 2022 - Taylor & Francis
Objectives Revascularization is necessary in patients with ischemic stroke, however it does
not address inflammation that contribute to reperfusion injury and the early growth of …

Therapeutic Investigation of CLEFMA in a Murine Model of Intestinal Ischemia-Reperfusion Injury

D Marchi - 2022 - search.proquest.com
Intestinal ischemic-reperfusion injury (IRI) occurs when vascular blood flow is interrupted in
the mesenteric vessels, followed by reperfusion when blood flow is re-established to the …

Differential oxidative and pro-apoptotic response of cancer and normal cells to an anti-inflammatory agent CLEFMA

K Sahoo, V Awasthi - bioRxiv, 2021 - biorxiv.org
Selective killing of cancer cells by chemotherapy has been an age old challenge, but certain
unique features of cancer cells allow discriminatory response between cancer and normal …

Small molecule rpn13 inhibitors with antitumor properties

RBS Roden, RK Anchoori - US Patent App. 17/781,507, 2023 - Google Patents
C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with
other rings, with one nitrogen atom as the only ring hetero atom and three or more double …